CCG
TEVA icon

Coastwise Capital Group’s Teva Pharmaceuticals TEVA Stock Holding History

Coastwise Capital Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,100
Closed -$83K – 104
2022
Q2 		$83K Sell
11,100
-600
-5% -$5.23K 0.1% 105
2022
Q1 		$110K Buy
+11,700
New +$97.6K 0.14% 98

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Coastwise Capital Group's TEVA Position: Q3 2022 in Review

Coastwise Capital Group sold out of Teva Pharmaceuticals (TEVA) in Q3 2022, closing a stake of 11,100 shares — an estimated $83K sold.

Coastwise Capital Group first reported a position in TEVA in Q1 2022 and held it in 2 quarters. The position peaked at $110K in Q1 2022. 430 funds tracked by Wall St. Rank hold TEVA as of Q3 2022.

  • Coastwise Capital Group reported no remaining Teva Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Coastwise Capital Group sold 11,100 Teva Pharmaceuticals shares in Q3 2022, an estimated $83K.
  • Coastwise Capital Group first reported a position in Teva Pharmaceuticals in Q1 2022 and held it in 2 quarters.
  • Coastwise Capital Group's Teva Pharmaceuticals position peaked at $110K in Q1 2022.
  • 430 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2022.

Based on Coastwise Capital Group's 13F filing for Q3 2022, filed 10 Nov 2022.